Archive


Category: appointment

  • Handover of senior R&D roles at Merck continues, as Roy Baynes exits

    Merck & Co’s chief medical officer and head of clinical development Dr Roy Baynes has announced his retirement from the company to take up a new role alongside his former colleague Roger Perlmutter at biotech Eikon Therapeutics. Baynes will bring a nine-year stint at Merck, known as MSD outside North America, to an end in […]

  • Psychedelics startup Beckley attracts Janssen neuroscience VP

    Psychedelic medicines specialist Beckley Psytech has enticed a senior figure in Janssen’s neuroscience division to take on the role of its chief medical officer as it ushers its first drugs through clinical trials. Dr Frank Wiegand is joining Beckley after more than two decades at Janssen and parent company Johnson & Johnson, most recently as […]